Hospital
Newton Healthcare Corporation
Newton Healthcare Corporation was paid $1.20M by Medicaid between Jan 2018 and Nov 2024, across 70 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoNEWTON HEALTHCARE CORPORATION
NEWTON, KS 67114
NEWTON, KS 67114
33aNPI1245238435assigned 07/12/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.20M
24GClaims61,840
24DCodes billed70
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kansas
Rank by total paid#17 of 48
Median peer was paid$461K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,097 | $197K | |
| 2019 | 9,876 | $187K | |
| 2020 | 7,080 | $151K | |
| 2021 | 7,345 | $183K | |
| 2022 | 8,971 | $189K | |
| 2023 | 9,135 | $143K | |
| 2024incomplete | 6,336 | $147K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 9,978 | 9,647 | $425K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 7,021 | 6,695 | $256K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 12% | 1,581 | 917 | $144K |
| 80053 | Comprehensive metabolic panel | 6.1% | 8,484 | 7,200 | $73K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.6% | 418 | 407 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.3% | 10,648 | 9,129 | $39K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.2% | 2,261 | 2,171 | $38K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.2% | 77 | 76 | $26K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 1,338 | 1,267 | $22K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 692 | 651 | $18K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 270 | 266 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,220 | 1,076 | $10K |
58 more codes
| 83735 | <1% | 1,525 | $9K | |
| 83615 | <1% | 1,476 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 813 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 321 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 63 | $5K |
| 31720 | <1% | 111 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 77 | $5K |
| 84484 | <1% | 535 | $4K | |
| 71045 | Radiologic examination, chest; single view | <1% | 316 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 109 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 113 | $3K |
| 87631 | <1% | 30 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 50 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 261 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 25 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 173 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 515 | $2K |
| 83690 | <1% | 254 | $2K | |
| 81003 | <1% | 1,312 | $1K | |
| 97597 | <1% | 20 | $1K | |
| 99285 | Emergency room visit (most serious) | <1% | 28 | $1K |
| 87581 | <1% | 77 | $997.75 | |
| 87486 | <1% | 77 | $997.74 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 119 | $980.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 28 | $939.89 |
| 81001 | <1% | 347 | $908.18 | |
| 81025 | <1% | 108 | $786.15 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 345 | $467.25 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $400.48 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 144 | $389.09 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $387.58 |
| 87800 | <1% | 12 | $328.29 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 55 | $315.11 |
| 82248 | <1% | 117 | $292.88 | |
| 80061 | Lipid panel | <1% | 32 | $287.20 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,081 | $202.99 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 34 | $186.24 |
| 83880 | <1% | 12 | $167.52 | |
| 87186 | <1% | 29 | $166.53 | |
| 87075 | <1% | 31 | $146.27 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,396 | $143.85 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $113.46 |
| 87081 | <1% | 12 | $101.93 | |
| 87070 | <1% | 31 | $86.13 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 61 | $70.56 |
| 85610 | <1% | 72 | $67.00 | |
| 85027 | <1% | 13 | $59.07 | |
| 83605 | <1% | 13 | $53.26 | |
| 87205 | <1% | 31 | $48.51 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 87 | $35.05 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 82 | $32.85 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 38 | $12.97 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 36 | $11.31 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 88 | $7.63 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 823 | $3.07 |
| A9270 | Non-covered item or service | 0% | 129 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 52 | $0.00 |
| 36416 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGLEASON, VALLERIE (PRESIDENT & CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Newton Healthcare Corporation | Newton, KS | $473K |
| Newton Healthcare Corporation | Newton, KS | $233K |
| Newton Healthcare Corporation | Newton, KS | $3K |
| Newton Healthcare Corporation | Newton, KS | $4.88 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.